Bob Whitehead

Bob Whitehead is a co-founder of Sprout Pharmaceuticals, where he collaborated with his then-wife Cindy Eckert to develop Addyi, a medication aimed at treating hypoactive sexual desire disorder (HSDD) in women. His background in pharmaceutical development and business strategy played a crucial role in the early stages of the company's efforts to gain FDA approval for the drug, which has since sparked significant discussions about women's sexual health.